Jenburkt Pharmaceuticals Ltd Reports Standalone Unaudited Financial Results for Q3 and Nine Months Ended on 31st December, 2025

Jenburkt Pharmaceuticals Ltd has reported its standalone unaudited financial results for the quarter and nine months ended on 31st December, 2025. The company's revenue from operations for the quarter is Rs. 15,160.15 lacs and for the nine months is Rs. 11,548.54 lacs. The profit before tax for the quarter is Rs. 1,433.20 lacs and for the nine months is Rs. 3,209.74 lacs. The profit after tax for the quarter is Rs. 1,016.34 lacs and for the nine months is Rs. 2,352.40 lacs. The company has made an additional provision in Employee Benefit Expense in compliance with the new Labour Codes on Wages 2019.